Panelists discuss how payer access challenges can determine whether patients receive therapy at all, with strategies including hospitalization for first cycles, advance prescription preparation, and recognition that oral regimens significantly impact quality of life for patients requiring lifelong treatment.Patients seeking oral acute myeloid leukemia (AML) treatments face significant access barriers through insurance coverage policies that […]
